A 2 Week, Randomized, Double-masked, Controlled, Parallel Group and 1 Week Follow-up Study to Evaluate Tolerability, Safety and Efficacy of Lubricin (150 µg/ml) Eye Drops Versus Sodium Hyaluronate (HA) 0.18% Eye Drops in Patients With Moderate Dry Eye (DE)
Phase of Trial: Phase II
Latest Information Update: 01 Oct 2016
At a glance
- Drugs Lubricin (Primary)
- Indications Dry eyes
- Focus Adverse reactions
- Sponsors Dompe Farmaceutici
- 01 Oct 2016 New trial record
- 20 Sep 2016 Results published in the September issue of The Ocular Surface, as per Lubris BioPharma media release.
- 20 Sep 2016 Results published in Lubris BioPharma media release.